Related Experiment Video
Updated: Jun 27, 2026
08:44
The Utility of Stage-specific Mid-to-late Drosophila Follicle Isolation
Published on: December 2, 2013
11.7K
Can aspirin help?
Ashwini Kalantri1, Shriprakash Kalantri2
1Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram, India.
Elife
|March 22, 2018
Summary
Aspirin, anti-tuberculosis drugs, and steroids may reduce strokes and deaths in tuberculous meningitis patients. This combination therapy shows promise for improving outcomes in this serious neurological condition.
Area of Science:
- Neurology
- Infectious Diseases
- Pharmacology
Background:
- Tuberculous meningitis (TBM) is a severe infection of the brain's lining.
- TBM is associated with high rates of stroke and mortality.
- Current treatment guidelines require optimization for better patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of a combination therapy including aspirin, anti-tuberculosis drugs, and steroids.
- To determine the impact of this regimen on reducing stroke incidence and mortality in TBM patients.
Main Methods:
- Retrospective analysis of patient data.
- Comparison of outcomes between patients receiving the combination therapy and standard care.
- Assessment of stroke events and mortality rates.
Main Results:
- The combination therapy group showed a statistically significant reduction in stroke occurrences.
- Mortality rates were lower in patients treated with aspirin, anti-tuberculosis drugs, and steroids.
- Adverse events were monitored and deemed manageable.
Conclusions:
- Combination therapy with aspirin, anti-tuberculosis drugs, and steroids appears beneficial for TBM patients.
- This approach may be a valuable strategy to decrease neurological complications and improve survival in tuberculous meningitis.
- Further prospective studies are warranted to confirm these findings.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...